Australia

Wed
15
Aug

Why do Aussies self-medicate with cannabis?

A survey has looked into how Australians use illicit cannabis to treat health conditions.

Australians who use illicit cannabis for medical reasons do so mainly to treat mental health issues, chronic pain, and sleep problems.

An anonymous online survey of 1748 participants was conducted in April to October 2016—immediately prior to the 2016 legislation for frameworks for medicinal cannabis use being passed.

Researchers from the University of Sydney found the most frequent reasons for medicinal cannabis use were to treat anxiety (50.7%), back pain (50%), depression (49.3%), and sleep problems (43.5%).

Respondents had used medicinal cannabis an average of 19.9 days of the previous 28 days, and a median of 26 of the preceding 28 days.

Wed
01
Aug

Australian medical marijuana patients can’t get any cannabis

Restrictive medical cannabis laws and few doctors willing to prescribe cannabis in Australia mean many sick people are stuck with the black market.

In Australia, a continent-country of 24 million people, there are 38,000 physicians licensed to work as general practitioners.

In Australia, a country where medical marijuana has been legal since 2016 for anyone with a doctor’s note to use it, there is exactly one general practitioner — out of 38,000 — who is an “authorized prescriber for medical cannabis,” according to the president of the country’s most prominent organization representing doctors.

Fri
27
Jul

What marijuana production in Australia could mean for commercial real estate

The legalisation of medical marijuana in Australia and the speculation that recreational marijuana may well be next could open up fresh possibilities for commercial real estate in Australia as major players race to establish domestic manufacturing facilities.

Fri
27
Jul

Aphria sees biggest cannabis oil export to date

Aphria (TSX:APH) has completed its largest export of cannabis oil to date through a shipment to Australia’s Medlab Clinical (ASX:MDC), it announced on Thursday (July 26).

Fri
20
Jul

Australian study shows that even low CBD extracts can treat epileptic seizures

It’s been widely believed that CBD is the compound in cannabis with medicinal value, but a new study out of Australia shows that THC shouldn’t be discounted in medical use either, wrirtes Jericho Knopp.

The study, out of the University of Sydney, looked at parents who turned to medicinal cannabis to treat epileptic seizures in their children, many of who were getting their drugs through the black market.

Thu
05
Jul

Australian scientists are developing medical cannabis for your pets

Australians spend over $12 billion a year on looking after our pets, with vet fees being of the biggest expenses. Sadly, medication for our fluffy friends can also have awful side effects, such as nausea, loss of appetite, depression and internal bleeding.

That's where animal-focused pharmaceutical CannPal is hoping to change things. Working with the CSIRO under its Kick-start program, the company is researching ways to avoid these negative effects with medicinal cannabis.

The CannPal website talks about the science behind the research, stating that all mammals have biological and neurological systems that can receive and process nutritional cannabinoids.

Wed
04
Jul

'This is just nonsense,' experts push back against south Australia's proposed crackdown on cannabis

South Australia - which was the first Australian state to decriminalize cannabis possession back in 1987 - is looking to drastically increase the maximum fines people can receive if caught with cannabis, writes Calvin Hughes. The push comes straight from South Australia's Attorney General Vickie Chapman, who is looking to toughen up the state's drug laws after a 2012 murder was committed by a young man who had consumed cannabis.

Wed
27
Jun

Cann Group to build Australia's largest medicinal cannabis operation

Listed medicinal cannabis company Cann Group (ASX: CAN) has signed an agreement to build Australia's largest state-of-the-art medicinal cannabis operation.

The cannabis cultivation facility will see Cann Group investing $100 million in the 37,000 square meter facility in the Melbourne Airport precinct.

Australia Pacific Airports Melbourne (APAM) will undertake the primary build of the site which is being designed by Aurora Larssen Projects, a specialist greenhouse engineering consultancy group that provides technical consulting to the greenhouse industry worldwide.

Cann will complete the fit-out and technology deployment required at the facility that, when completed, will employ 170 staff.

Mon
25
Jun

Australia's first medicinal cannabis clinic set to open

The first of 10 medical cannabis clinics to be launched in Melbourne will open later this year with approval from the state and federal government. 

New legislation allows doctors to prescribe cannabis treatments which will be available to adults and children, Herald Sun reported. 

CannaLife founder Helen Lyon predicts the number of patients, who will be approved to legally use medical marijuana, is expected to grow significantly with the opening of the clinic in 2016. 

Fri
01
Jun

Australian brand launches first Japanese medicinal cannabis campaign

Australian medicinal cannabis company Elixinol has launched Japan’s first campaign advertising their products following a long-fought battle with regulators.

The ASX listed company has become the first to gain approval for a billboard advertising cannabidiol hemp oil – commonly known as CBD – in the country where medical marijuana has faced a fierce backlash by lawmakers.

Although CBD was legalised in November 2016, brands have so far struggled to gain approval to market their products, Elixinol Japan’s boss said in a statement.

Pages

Subscribe to RSS - Australia